DARLA STILES: Open Payments
NPI 1033538764 · MEDFORD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 22 payments from 9 companies in 2025. Trend: 2023 $298 · 2024 $467 · 2025 $501
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $116 |
| GlaxoSmithKline, LLC. | 4 | $104 |
| Novo Nordisk Inc | 4 | $94 |
| Amgen Inc. | 2 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Hologic Sales and Service, LLC | 1 | $27 |
| Astellas Pharma US Inc | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
Products named: TRELEGY ELLIPTA, Ozempic, NURTEC ODT, FARXIGA, EVENITY, AREXVY, APTIMA, OTEZLA.
Industry payments across OR — which companies pay providers there.
